{
 "generic_name": "Hydromorphone Hydrochloride Injection",
 "slug": "hydromorphone-hydrochloride-injection",
 "brand_names": [
  "Dilaudid",
  "Hydromorphone Hydrochloride"
 ],
 "fda_status": [
  "Current"
 ],
 "last_fda_update": "09/22/2026",
 "first_posted": "10/31/2017",
 "synced_at": "2026-10-01T04:04:04.751Z",
 "presentations": [
  {
   "company": "Fresenius Kabi USA, LLC",
   "package_ndc": "76045-121-11",
   "presentation": "Dilaudid, Injection, .2 mg/1 mL (NDC 76045-121-11)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Next release November 2026. Check wholesalers for inventory."
  },
  {
   "company": "Fresenius Kabi USA, LLC",
   "package_ndc": "76045-009-11",
   "presentation": "Dilaudid, Injection, 1 mg/1 mL (NDC 76045-009-11)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Next release October 2026. Check wholesalers for inventory."
  },
  {
   "company": "Fresenius Kabi USA, LLC",
   "package_ndc": "63323-852-25",
   "presentation": "Hydromorphone Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-852-25)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Next release October 2026. Check wholesalers for inventory."
  },
  {
   "company": "Fresenius Kabi USA, LLC",
   "package_ndc": "76045-009-06",
   "presentation": "Dilaudid, Injection, 1 mg/1 mL (NDC 76045-009-06)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Next release September 2026. Check wholesalers for inventory."
  },
  {
   "company": "Hospira, Inc., a Pfizer Company",
   "package_ndc": "0409-1283-37",
   "presentation": "Hydromorphone Hydrochloride, Injection, 1 mg/1 mL (NDC 0409-1283-37)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay"
  },
  {
   "company": "Hospira, Inc., a Pfizer Company",
   "package_ndc": "0409-1283-31",
   "presentation": "Hydromorphone Hydrochloride, Injection, 1 mg/1 mL Syringes (NDC 0409-1283-31)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": null
  },
  {
   "company": "Fresenius Kabi USA, LLC",
   "package_ndc": "76045-010-11",
   "presentation": "Dilaudid, Injection, 2 mg/1 mL (NDC 76045-010-11)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Next release not available at this time.  Check wholesalers for inventory."
  },
  {
   "company": "Fresenius Kabi USA, LLC",
   "package_ndc": "63323-853-25",
   "presentation": "Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 63323-853-25)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Next release September 2026. Check wholesalers for inventory."
  },
  {
   "company": "Hikma Pharmaceuticals USA, Inc.",
   "package_ndc": "0641-6254-01",
   "presentation": "Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0641-6254-01)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Product temporarily on backorder.  Additional lots will be available in the September 2026 timeframe."
  },
  {
   "company": "Hospira, Inc., a Pfizer Company",
   "package_ndc": "0409-1312-36",
   "presentation": "Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0409-1312-36)",
   "availability": "Limited",
   "availability_raw": "Limited Availability",
   "fda_note": "Limited Supply Available. Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay"
  },
  {
   "company": "Hikma Pharmaceuticals USA, Inc.",
   "package_ndc": "0641-0121-25",
   "presentation": "Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0641-0121-25)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": "Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released."
  },
  {
   "company": "Hospira, Inc., a Pfizer Company",
   "package_ndc": "0409-3365-10",
   "presentation": "Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0409-3365-10)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": null
  },
  {
   "company": "Hospira, Inc., a Pfizer Company",
   "package_ndc": "0409-1312-30",
   "presentation": "Hydromorphone Hydrochloride, Injection, 2 mg/1 mL Syringes (NDC 0409-1312-30)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": null
  },
  {
   "company": "Fresenius Kabi USA, LLC",
   "package_ndc": "63323-854-10",
   "presentation": "Hydromorphone Hydrochloride, Injection, 4 mg/1 mL (NDC 63323-854-10)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": "Check wholesalers for inventory"
  },
  {
   "company": "Hospira, Inc., a Pfizer Company",
   "package_ndc": "0409-1304-31",
   "presentation": "Hydromorphone Hydrochloride, Injection, 4 mg/1 mL Syringes (NDC 0409-1304-31)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": null
  },
  {
   "company": "Teva Pharmaceuticals USA, Inc.",
   "package_ndc": "0703-0113-03",
   "presentation": "Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0113-03)",
   "availability": "Limited",
   "availability_raw": "Limited Availability",
   "fda_note": "Estimated recovery: TBD"
  },
  {
   "company": "Fresenius Kabi USA, LLC",
   "package_ndc": "63323-851-15",
   "presentation": "Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-15)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": "Check wholesaler for inventory"
  },
  {
   "company": "Fresenius Kabi USA, LLC",
   "package_ndc": "63323-851-10",
   "presentation": "Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-10)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": "Check wholesalers for inventory"
  },
  {
   "company": "Fresenius Kabi USA, LLC",
   "package_ndc": "63323-851-50",
   "presentation": "Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-50)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": "Check wholesalers for inventory"
  },
  {
   "company": "Hospira, Inc., a Pfizer Company",
   "package_ndc": "0409-2634-01",
   "presentation": "Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0409-2634-01)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": null
  },
  {
   "company": "Teva Pharmaceuticals USA, Inc.",
   "package_ndc": "0703-0110-03",
   "presentation": "Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0110-03)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": null
  },
  {
   "company": "Teva Pharmaceuticals USA, Inc.",
   "package_ndc": "0703-0018-01",
   "presentation": "Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0018-01)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": null
  },
  {
   "company": "Hospira, Inc., a Pfizer Company",
   "package_ndc": "0409-1805-01",
   "presentation": "Hydromorphone Hydrochloride, Injection, 0.25 mg/ 0.5 mL NexJect™ Single-dose Syringe Luer Lock (no needle) (NDC 0409-1805-01)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay"
  },
  {
   "company": "Hospira, Inc., a Pfizer Company",
   "package_ndc": "0409-4264-01",
   "presentation": "Hydromorphone Hydrochloride, Injection, 0.5 mg/0.5 mL NexJect™ Single-dose Syringe Luer Lock (no needle) (NDC 0409-4264-01)",
   "availability": "Limited",
   "availability_raw": "Limited Availability",
   "fda_note": "Limited Supply Available. Next Delivery: September 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay"
  },
  {
   "company": "Hospira, Inc., a Pfizer Company",
   "package_ndc": "0409-2634-05",
   "presentation": "Hydromorphone Hydrochloride, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-2634-05)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": null
  },
  {
   "company": "Hospira, Inc., a Pfizer Company",
   "package_ndc": "0409-2634-50",
   "presentation": "Hydromorphone Hydrochloride, Injection, 500 mg/50 mL (10 mg/mL) (NDC 0409-2634-50)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": null
  }
 ],
 "changes": []
}